2-[[4-(1,2-oxazol-3-ylmethyl)-2-(pyridin-2-ylmethyl)-3-(1,3-thiazol-2-ylmethyl)-1-benzofuran-5-yl]methyl]-1,3-oxazole
C26H20N4O3S — CID 141170647
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[[4-(1,2-oxazol-3-ylmethyl)-2-(pyridin-2-ylmethyl)-3-(1,3-thiazol-2-ylmethyl)-1-benzofuran-5-yl]methyl]-1,3-oxazole
2-[[4-(1,2-oxazol-3-ylmethyl)-2-(pyridin-2-ylmethyl)-3-(1,3-thiazol-2-ylmethyl)-1-benzofuran-5-yl]methyl]-1,3-oxazole (PubChem CID 141170647) has the molecular formula C26H20N4O3S and a molecular weight of 468.54 g/mol. Its IUPAC name is 2-[[4-(1,2-oxazol-3-ylmethyl)-2-(pyridin-2-ylmethyl)-3-(1,3-thiazol-2-ylmethyl)-1-benzofuran-5-yl]methyl]-1,3-oxazole.
Molecular Properties
| Compound Name | 2-[[4-(1,2-oxazol-3-ylmethyl)-2-(pyridin-2-ylmethyl)-3-(1,3-thiazol-2-ylmethyl)-1-benzofuran-5-yl]methyl]-1,3-oxazole |
|---|---|
| PubChem CID | 141170647 |
| Molecular Formula | C26H20N4O3S |
| Molecular Weight | 468.54 g/mol |
| Exact Mass | 468.13 |
| IUPAC Name | 2-[[4-(1,2-oxazol-3-ylmethyl)-2-(pyridin-2-ylmethyl)-3-(1,3-thiazol-2-ylmethyl)-1-benzofuran-5-yl]methyl]-1,3-oxazole |
| SMILES | c1ccc(Cc2oc3ccc(Cc4ncco4)c(Cc4ccon4)c3c2Cc2nccs2)nc1 |
| InChI | InChI=1S/C26H20N4O3S/c1-2-7-27-18(3-1)15-23-21(16-25-29-9-12-34-25)26-20(14-19-6-10-32-30-19)17(4-5-22(26)33-23)13-24-28-8-11-31-24/h1-12H,13-16H2 |
| InChIKey | IDHIKTYXBJWFCP-UHFFFAOYSA-N |
| XLogP | 5.62 |
| TPSA | 90.98 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 468.54 |
| LogP ≤ 5 | 5.62 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141170647 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.